---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-000947"
form_type: "8-K"
ticker: null
cik: "0000922247"
company_name: "Cyclo Therapeutics, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T04:21:44.283763+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cyclo Therapeutics receives Nasdaq notice for failing to hold annual meeting; must submit plan by Feb 24, 2025

## Summary
- Received Nasdaq letter on Jan 10, 2025 citing non-compliance with Listing Rules 5620(a) and 5810(c)(2)(G).
- Company has 45 days (until Feb 24, 2025) to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant up to 180 days (until June 30, 2025) to hold the meeting.

## SEC filing metadata
- accession: 0001437749-25-000947
- form_type: 8-K
- cik: 0000922247
- company_name: Cyclo Therapeutics, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/922247/000143774925000947/0001437749-25-000947-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/922247/000143774925000947/ctdh20250113_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-000947
- JSON: https://secwatch.observer/filing/0001437749-25-000947.json
- Plain text: https://secwatch.observer/filing/0001437749-25-000947.txt

## Source-grounded claims
- claim_id: 64066d6cfab709767853acbdee553e5f2b126811
  claim: Cyclo Therapeutics, Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a), 5810(c)(2)(G)).
  evidence_excerpt: January 10, 2025, Cyclo Therapeutics, Inc. (the "Company”) received a letter from The Nasdaq Stock Market ("Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rules 5620(a) and 5810(c)(2)(G) for
  evidence_url: https://www.sec.gov/Archives/edgar/data/922247/000143774925000947/0001437749-25-000947-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.